Rebozo and External Cephalic Version in Breech Presentation.
RECeiVe
Rebozo Som Vendingsmetode Ved sædepræsentation (in Danish)
1 other identifier
interventional
370
1 country
1
Brief Summary
Breech presentation occurs in approximately 3-5% of all pregnancies, and breech birth is more complicated and risky for the fetus than births of fetuses in the cephalic position. Therefore, it is desirable to turn the fetus from breech presentation to cephalic position before labour. This is traditionally done by external cephalic version, where the doctor manually tries to turn the fetus; the success rate of this is approximately 50%, and complications occur in about 0.5%. In addition there is discomfort and pain to the pregnant woman. The investigators will assess the effect of using the rebozo prior to the external version. Use of rebozo is a recognized technique from Mexico, where the midwife with a scarf 'shake' the pregnant woman's pelvis over several sessions, so the fetus spontaneously turns to cephalic presentation or the external version is facilitated. There are no known complications associated with the rebozo method. Use of rebozo in breech presentation has never before been studied scientifically, but is used in many places in the world. The investigators are planning an open-labeled randomized controlled study in pregnancies with verified breech or transverse presentation: by lot either standard external cephalic version or preceding rebozo-treatment with subsequent external cephalic version. The investigators want to assess whether the use of rebozo - either as pre-treatment for external cephalic version or as a catalyst of spontaneous version - will increase the incidence of the cephalic presentations at labour and thus reduce the number of planned caesarean section. The population will be pregnant women with ultrasound verified breech or transverse presentation;all women who fulfill the local guideline criteria for external cephalic version, can be included. Exclusion criteria are non-Danish speaking or reading. The recruitment will be conducted by midwife at week 35 in the antenatal care. The study design will be open-labeled randomized controlled. Randomisation is done by "closed envelope method" and stratified by parity. Intervention is rebozo exercises performed over 3-5 days from randomization. In case of persistent breech presentation, the woman is offered standard external cephalic version. The control group will also be offered external cephalic version after 3-5 days from randomization. The investigators will use source data from existing local databases, "Obstetrics Database" and "version Database", for collecting birth outcome. In all stages of intervention documented electronically by project midwives. The primary objective is the number of successful versions in total, i.e., after intervention and external cephalic version. We expect to increase the success rate from 50% to 65%, thus requiring 378 women in the study. Secondary objectives are the number of successful vaginal births with birth in head position and total number of caesarean.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2015
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 21, 2014
CompletedFirst Posted
Study publicly available on registry
January 6, 2015
CompletedStudy Start
First participant enrolled
March 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2018
CompletedFebruary 22, 2019
February 1, 2019
3.8 years
December 21, 2014
February 20, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Cephalic presentation
After external cephalic version
Secondary Outcomes (13)
Version rate by the intervention only
Before external cephalic version
Version rate by the standard external cephalic version
At the external cephalic version
Rate of cesarean section by intervention and presentation.
In labour
Dystocia in labor in cephalic presentation after version
In labour
Inducement of labour
Before labour
- +8 more secondary outcomes
Study Arms (2)
Rebozo
EXPERIMENTALIntervention by Rebozo
Control
NO INTERVENTIONStandard
Interventions
Shaking of the maternal pelvis by the midwife to increase the spontaneous cephalic version rate in breech presentation.
Eligibility Criteria
You may qualify if:
- Understands Danish in writing.
- Intention of accepting vaginal delivery if cephalic presentation.
- Can be offered standard treatment of external cephalic version according to local guidelines, e.g.:
- Singleton pregnancy
- Fetus in breech or transverse position
- The gestational age at randomization must be between 35w+0/7d and 37w+4/7d so that the ECV is no later than 38w+0/7d for parous and 37w + 0/7d for nulliparous women.
You may not qualify if:
- Women that cannot be offered external cephalic version according local guideline, e.g.:
- placenta praevia and vasa praevia.
- Suspicion of severe fetal growth restriction.
- Severe preeclampsia.
- Uterus anomalies.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hvidovre Hospital, dept. of Obstetrics
Copenhagen, Hvidovre, 2650, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jacob Alexander Lykke, MD PhD
Ass. prof., consultant
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Ass. professor, consultant, MD PhD
Study Record Dates
First Submitted
December 21, 2014
First Posted
January 6, 2015
Study Start
March 1, 2015
Primary Completion
December 31, 2018
Study Completion
December 31, 2018
Last Updated
February 22, 2019
Record last verified: 2019-02